Neurodevelopmental Outcomes Following Late and Moderate Prematurity: a Population-based Cohort Study
Overview
Pediatrics
Authors
Affiliations
Objective: There is a paucity of data relating to neurodevelopmental outcomes in infants born late and moderately preterm (LMPT; 32(+0)-36(+6) weeks). This paper present the results of a prospective, population-based study of 2-year outcomes following LMPT birth.
Design: 1130 LMPT and 1255 term-born children were recruited at birth. At 2 years corrected age, parents completed a questionnaire to assess neurosensory (vision, hearing, motor) impairments and the Parent Report of Children's Abilities-Revised to identify cognitive impairment. Relative risks for adverse outcomes were adjusted for sex, socio-economic status and small for gestational age, and weighted to account for over-sampling of term-born multiples. Risk factors for cognitive impairment were explored using multivariable analyses.
Results: Parents of 638 (57%) LMPT infants and 765 (62%) controls completed questionnaires. Among LMPT infants, 1.6% had neurosensory impairment compared with 0.3% of controls (RR 4.89, 95% CI 1.07 to 22.25). Cognitive impairments were the most common adverse outcome: LMPT 6.3%; controls 2.4% (RR 2.09, 95% CI 1.19 to 3.64). LMPT infants were at twice the risk for neurodevelopmental disability (RR 2.19, 95% CI 1.27 to 3.75). Independent risk factors for cognitive impairment in LMPT infants were male sex, socio-economic disadvantage, non-white ethnicity, preeclampsia and not receiving breast milk at discharge.
Conclusions: Compared with term-born peers, LMPT infants are at double the risk for neurodevelopmental disability at 2 years of age, with the majority of impairments observed in the cognitive domain. Male sex, socio-economic disadvantage and preeclampsia are independent predictors of low cognitive scores following LMPT birth.
Writhing Movements and Hypoglycemia in Moderate-Late Preterm Infants: A Prospective Cohort Study.
Merino-Andres J, Fernandez-Rego F, Hidalgo-Robles A, Cayeiro-Marin M, Lopez-Munoz P, Perez-Nombela S Children (Basel). 2025; 12(2).
PMID: 40003276 PMC: 11854476. DOI: 10.3390/children12020174.
Alenezi S, Aldaihani M, Alqabandi S, Alkandari A, Almukaimi B, Almutairi L Cureus. 2024; 16(12):e76110.
PMID: 39711931 PMC: 11662373. DOI: 10.7759/cureus.76110.
Cohen J, De Bie F, Viaene A, OGrady N, Rentas S, Coons B Sci Rep. 2024; 14(1):28840.
PMID: 39572605 PMC: 11582712. DOI: 10.1038/s41598-024-79095-7.
Neurodevelopment at Age 9 Years Among Children Born at 32 to 36 Weeks' Gestation.
Cheong J, Mainzer R, Doyle L, Olsen J, Ellis R, FitzGerald T JAMA Netw Open. 2024; 7(11):e2445629.
PMID: 39556392 PMC: 11574691. DOI: 10.1001/jamanetworkopen.2024.45629.
Zhang H, Lin J, Zhao H Int J Mol Sci. 2024; 25(20).
PMID: 39456854 PMC: 11508320. DOI: 10.3390/ijms252011062.